AllianceBernstein’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.43M Hold
127,093
﹤0.01% 2100
2025
Q1
$1.2M Sell
127,093
-660
-0.5% -$6.25K ﹤0.01% 2148
2024
Q4
$1.44M Sell
127,753
-100,004
-44% -$1.13M ﹤0.01% 2132
2024
Q3
$6.44M Buy
227,757
+64,639
+40% +$1.83M ﹤0.01% 1407
2024
Q2
$3.12M Sell
163,118
-144,143
-47% -$2.76M ﹤0.01% 1710
2024
Q1
$10.1M Sell
307,261
-40,551
-12% -$1.33M ﹤0.01% 1156
2023
Q4
$11.5M Buy
347,812
+15,398
+5% +$509K ﹤0.01% 1086
2023
Q3
$9.05M Buy
332,414
+38,084
+13% +$1.04M ﹤0.01% 1133
2023
Q2
$8.92M Buy
294,330
+167,829
+133% +$5.09M ﹤0.01% 1183
2023
Q1
$4.1M Sell
126,501
-23,169
-15% -$752K ﹤0.01% 1477
2022
Q4
$4.2M Buy
149,670
+58,870
+65% +$1.65M ﹤0.01% 1512
2022
Q3
$3.26M Hold
90,800
﹤0.01% 1597
2022
Q2
$2.79M Hold
90,800
﹤0.01% 1746
2022
Q1
$2.93M Buy
90,800
+200
+0.2% +$6.46K ﹤0.01% 1855
2021
Q4
$2.51M Sell
90,600
-11,600
-11% -$321K ﹤0.01% 1996
2021
Q3
$3.17M Sell
102,200
-5,500
-5% -$170K ﹤0.01% 1864
2021
Q2
$2.28M Buy
107,700
+14,400
+15% +$304K ﹤0.01% 2106
2021
Q1
$1.89M Buy
93,300
+2,100
+2% +$42.4K ﹤0.01% 2127
2020
Q4
$1.46M Hold
91,200
﹤0.01% 2137
2020
Q3
$1.13M Sell
91,200
-2,000
-2% -$24.8K ﹤0.01% 2118
2020
Q2
$664K Sell
93,200
-5,100
-5% -$36.3K ﹤0.01% 2419
2020
Q1
$534K Buy
98,300
+13,000
+15% +$70.6K ﹤0.01% 2312
2019
Q4
$772K Sell
85,300
-38
-0% -$344 ﹤0.01% 2374
2019
Q3
$614K Buy
85,338
+38
+0% +$273 ﹤0.01% 2447
2019
Q2
$678K Hold
85,300
﹤0.01% 2469
2019
Q1
$1.07M Hold
85,300
﹤0.01% 2214
2018
Q4
$1.7M Sell
85,300
-700
-0.8% -$14K ﹤0.01% 1911
2018
Q3
$2.44M Hold
86,000
﹤0.01% 1796
2018
Q2
$1.81M Buy
86,000
+24,277
+39% +$511K ﹤0.01% 1986
2018
Q1
$880K Buy
61,723
+1,123
+2% +$16K ﹤0.01% 2310
2017
Q4
$745K Buy
60,600
+2,100
+4% +$25.8K ﹤0.01% 2412
2017
Q3
$1.04M Hold
58,500
﹤0.01% 2244
2017
Q2
$1.48M Buy
58,500
+34,700
+146% +$880K ﹤0.01% 2032
2017
Q1
$531K Hold
23,800
﹤0.01% 2498
2016
Q4
$352K Buy
23,800
+5,400
+29% +$79.9K ﹤0.01% 2655
2016
Q3
$453K Buy
18,400
+3,900
+27% +$96K ﹤0.01% 2553
2016
Q2
$278K Buy
+14,500
New +$278K ﹤0.01% 2698